Gastrointestinal Cancer: Targets and Therapy

Dr O'Reilly

Department of Oncology, Memorial Sloan-Kettering Cancer Center, United States

Dr O'Reilly

Editor-in-Chief: Eileen M. O'Reilly

Dr Eileen M. O’Reilly serves as the associate director for clinical research for the David M. Rubenstein Center for Pancreas Cancer and is an attending physician and member at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and at Weill Medical College of Cornell University. Dr O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland, where she was born. She completed her residency training in Ireland and fellowship training at MSKCC. Dr O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research initiatives include integration of molecular and genetic-based therapies for the treatment of pancreatic cancer along with development of adjuvant and neoadjuvant therapies and identification of biomarkers that maybe used to select therapy. Dr O’Reilly teaches and mentors oncology fellows (national and international), junior faculty, residents and house-staff and has numerous teaching awards. Dr O’Reilly is the principal investigator of multiple phase I, II and III trials in pancreatic cancer and has authored/co-authored approximately 180 articles, editorials and book chapters. Dr O’Reilly’s other institutional responsibilities include associate chairpersonship of MSKCC’s Institutional Review & Privacy Board (IRB), and membership of the Research Council and she is the chair of the Continuing Medical Education (CME) committee. Nationally Dr O’Reilly is the chair of the NCI Pancreas Task Force, member of the Alliance GI Core committee, and serves on the scientific advisory board of the Pancreatic Cancer Action Network, NCCN Pancreas panel, Board of the National Pancreas Foundation and ASCO IMT committee.